RAIN - Rain Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RAIN is currently covered by 7 analysts with an average price target of $7.6. This is a potential upside of $5.73 (306.42%) from yesterday's end of day stock price of $1.87.

Rain Therapeutics's activity chart (see below) currently has 25 price targets and 33 ratings on display. The stock rating distribution of RAIN is 25% BUY and 75% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.86% with an average time for these price targets to be met of 125.86 days.

Highest price target for RAIN is $9, Lowest price target is $1, average price target is $0.63.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Sep-2023. First documented stock forecast 18-May-2021.

Currently out of the existing stock ratings of RAIN, 3 are a BUY (25%), 9 are a HOLD (75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1

$-1.09 (-52.15%)

$1.5

1 years 6 months 1 days ago
(18-Sep-2023)

2/6 (33.33%)

$0.16 (19.05%)

309

Hold

$1

$-1.09 (-52.15%)

$17

1 years 9 months 14 days ago
(05-Jun-2023)

1/5 (20%)

$-0.25 (-20.00%)

73

Hold

1 years 9 months 17 days ago
(02-Jun-2023)

2/3 (66.67%)

$10.01 (111.35%)

90

Hold

$1.75

$-0.34 (-16.27%)

$12

1 years 9 months 24 days ago
(23-May-2023)

2/5 (40%)

$0.51 (41.13%)

409

Hold

$17

1 years 9 months 24 days ago
(23-May-2023)

0/1 (0%)

$13.56 (394.19%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RAIN (Rain Therapeutics) average time for price targets to be met?

On average it took 125.86 days on average for the stock forecasts to be realized with a an average price target met ratio 22.86

Which analyst has the current highest performing score on RAIN (Rain Therapeutics) with a proven track record?

JOSEPH CATANZARO

Which analyst has the current lower performing score on RAIN (Rain Therapeutics) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on RAIN (Rain Therapeutics)?

Joseph Catanzaro works at PIPER SANDLER and has 9 price targets and 7 ratings on RAIN

Which analyst is the currently most bullish on RAIN (Rain Therapeutics)?

Michael Schmidt with highest potential upside - $18.79

Which analyst is the currently most reserved on RAIN (Rain Therapeutics)?

Graig Suvannavejh with lowest potential downside - -$1.09

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?